According to The Insight Partners, “Aesthetic Medicine Market Size, Share, Growth and Revenue Forecasts to 2028 – COVID-19 Impact and Global Analysis By Gender (Male and Female), Procedures [Invasive (Breast Augmentation, Liposuction, Nose Reshaping, Eyelid Surgery, Tummy Tuck, and Others) and Non-invasive (Botox Injections, Body Shaping & Carbon Peeling, Soft Tissue Fillers, Chemical Peel & Rejuvenation, Acne Treatment & Drainage Tonification, Permanent Hair Removal & Tattoo Removal, Microdermabrasion & Vascular Lesions, and Others)], Technologies (Acoustic Wave, Radiofrequency, Pressomassage, Oxygen Therapy, Diode Laser, and Others), End User (Hospital & Clinics, Medical Spas, Home Care, Beauty Centers, and Others), and Geography”; The aesthetic medicine market is expected to reach USD 233.84 billion by 2028 from USD 102.25 billion in 2022, growing at a CAGR of 14.8% from 2022 to 2028.
Download Sample Brochure at https://www.theinsightpartners.com/sample/TIPRE00006431
Rising Demand for Non-surgical Injectable Treatments
The rising demand for non-injectable treatments such as botox has aided the overall growth of the aesthetic medicine market. Botox is the brand name of a prescription only injectable medication manufactured by Allergan PLC., one of the international world leaders in cosmetic science and pharmaceuticals. Botox is derived from bacteria. The Botox protein has been used in medicine for over 60 years to safely treat various conditions in children as well as adults. Botox is licensed for 21 clinical indications across the globe, including squints, muscle spasms, cerebral palsy, excess sweating, bladder instability, and chronic migraine. It has been used for over 20 years for its benefits with reducing the appearance of wrinkles and recently, it has more uses in anti-aging applications. In the past half decade, the popularity of Botox treatments in the US has skyrocketed, with a 40.6 percent increase in procedures, according to the latest figures from the American Society for Aesthetic Plastic Surgery (ASAPS), and a 7% rise since 2017. In 2021, over 2.3 million Botox injections were carried out in the United States, according to the American Society for Aesthetic Plastic Surgery (ASAPS). Such a factor is expected to aid the overall market of aesthetic medicine in the recent past and is expected to continue a similar trend during the forecast period.
Check Discount on this Report at https://www.theinsightpartners.com/discount/TIPRE00006431
Global Aesthetic Medicine Market: Competitive Landscape and Key Developments
EME s.r.l; Fusion Meso; AbbVie; Galderma; Cynosure Aesthetics; Lumenis Be Ltd; Evolus, Inc.; Solta Medical; Syneron Candela; and Alma Lasers are a few of the key players profiled during the study of the aesthetic medicine market. The market is anticipated to flourish with the development of new innovative products by market players.
In December 2022, Tarsus Medical, who is one the leading providers of healthcare events and platforms, announces the launch of the Medical Aesthetics Professionals (MAP) Meeting to unite the Aesthetic Medicine community through high quality education programs and access to the latest technology to encompass all that is necessary for a successful practice.
Purchase Premium Copy of Aesthetic Medicine Market Growth Report (2022-2028) at: https://www.theinsightpartners.com/buy/TIPRE00006431
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Sameer Joshi
Press Release: https://www.theinsightpartners.com/pr/aesthetic-medicine-market